Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 77919 · Class II · BloodSource, Inc.
Key facts
| Event ID | 77919 |
|---|---|
| Recall numbers | B-0802-2017 |
| Recalling firm | BloodSource, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Apheresis products, in which platelet yield and component preparation did not meet specifications, were distributed. |
| Initiation date | Jul 3, 2017 |
| Report date | Aug 30, 2017 |
| Termination date | Aug 22, 2017 |
| City | Mather |
| State | CA |
| Country | United States |
| FEI number | 3007101464 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: